Evidence map›Paper›PMID 26931382›Full record

ArticleHuman mutation2016

ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.

Bobby G Ng, Sergey A Shiryaev, Daisy Rymen, Erik A Eklund, Kimiyo Raymond, Martin Kircher, Jose E Abdenur, Fusun Alehan, Alina T Midro, Michael J Bamshad and 50 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

60 authors at 20 institutions in 11 countries.

Bobby G NgHuman Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
Sergey A ShiryaevHuman Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
Daisy RymenCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Erik A EklundSection of Experimental Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
Kimiyo RaymondBiochemical Genetics Laboratory, Mayo Clinic College of Medicine, Rochester, Minnesota.
Martin KircherDepartment of Genome Sciences, University of Washington, Seattle, Washington.
Jose E AbdenurDivision of Metabolic Disorders, Children's Hospital of Orange County, Orange, California.
Fusun AlehanDivision of Pediatric Neurology, Baskent University School of Medicine, Ankara, Turkey.
Alina T MidroDepartment of Clinical Genetics, Medical University, Bialystok, Poland.
Michael J BamshadDepartment of Genome Sciences, University of Washington, Seattle, Washington.
Rita BaronePediatric Neurology Policlinico, University of Catania, Catania, Italy.
Gerard T BerryDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Jane E BrumbaughStead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, Iowa.
Kati J BuckinghamDepartment of Pediatrics, University of Washington, Seattle, Washington.
Katie ClarksonGreenwood Genetic Center, Greenwood, South Carolina.
F Sessions ColeDivision of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Shawn O'ConnorDivision of Newborn Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, Alabama.
Rudy Van CosterDepartment of Pediatrics, Division of Pediatric Neurology and Metabolism, University Hospital Gent, Gent, Belgium.
Laurie A DemmerClinical Genetics Program, Carolinas Health Care, Levine Childrens Hospital, Charlotte, North Carolina.
Luisa DiogoCentro de Desenvolvimento da Criança- Pediatric Hospital - CHUC, Coimbra, Portugal.
Alexander J FayDivision of Pediatric Neurology, Washington University, St. Louis, Missouri.
Can FiciciogluDepartment of Pediatrics, Section of Metabolic Disease, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania.
Agata FiumaraCentre for Inherited Metabolic Diseases, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
William A GahlNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, Maryland.
Rebecca GanetzkyDepartment of Pediatrics, Section of Metabolic Disease, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania.
Himanshu GoelHunter Genetics, Waratah, New South Wales, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Lyndsay A HarshmanStead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, Iowa.
Miao HeDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jaak JaekenCenter for Metabolic Diseases, University Hospital of Leuven, Leuven, Belgium.
Philip M JamesDivision of Genetics & Metabolism, Phoenix Children's Hospital, Phoenix, Arizona.
Daniel KatzPediatric Neurology, Stormont-Vail Health Care, Topeka, Kansas.
Liesbeth KeldermansCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Maria KibaekDepartment of Pediatrics, Odense University Hospital, Odense, Denmark.
Andrew J KornbergDepartment of Neurology, Royal Children's Hospital, Parkville, Victoria, Australia.
Katherine LachlanHuman Genetics and Genomic Medicine, University of Southampton and Wessex Clinical Genetics Service, Southampton, United Kingdom.
Christina LamNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Joy Yaplito-LeeDepartment of Metabolic Medicine, Royal Children's Hospital, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Deborah A NickersonDepartment of Genome Sciences, University of Washington, Seattle, Washington.
Heidi L PetersDepartment of Metabolic Medicine, Royal Children's Hospital, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Valerie RaceCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Luc RégalDepartment of Pediatric Neurology and Metabolism, University Hospital of Brussels, Brussels, Belgium.
Jeffrey S RushDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.
S Lane RutledgeDepartment of Genetics, University of Alabama at Birmingham, Birmingham, Alabama.
Jay ShendureDepartment of Genome Sciences, University of Washington, Seattle, Washington.
Erika SoucheCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Susan E SparksCarolinas Healthcare System, Charlotte, North Carolina.
Pamela TrapaneStead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, Iowa.
Amarilis Sanchez-ValleDivision of Genetics and Metabolism, University of South Florida, Tampa, Florida.
Eric VilainDepartment of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Arve VølloDepartment of Pediatrics, Hospital of Ostfold N-1603 Fredrikstad, Norway.
Charles J WaechterDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky.
Raymond Y WangDivision of Metabolic Disorders, Children's Hospital of Orange County, Orange, California.
Lynne A WolfeNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, Maryland.
Derek A WongDepartment of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Tim WoodGreenwood Genetic Center, Greenwood, South Carolina.
Amy C YangDepartment of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, New York.
University of Washington Center for Mendelian Genomics
Gert MatthijsCenter for Human Genetics, University of Leuven, Leuven, Belgium.
Hudson H FreezeHuman Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
KU Leuven · BEUniversity of Washington · USDiscovery Institute · USUniversity of Iowa Stead Family Children’s Hospital · USWashington University in St. Louis · USChildren's Hospital of Philadelphia · USGreenwood Genetic Center · USNational Human Genome Research Institute · USRoyal Children's Hospital · AUUniversity of California, Los Angeles · USUniversity of Kentucky · USBaşkent University · TRCarolinas Healthcare System · USChildren's Hospital of Orange County · USErasmus Hospital · BEGhent University Hospital · BEHarvard University · USHospitais da Universidade de Coimbra · PTHoward Hughes Medical Institute · USHudsonAlpha Institute for Biotechnology · US

Funding

NHGRI/DIR Clinical Support ServicesZIDHG200352 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SOLOMON, BENJAMIN · 2009 to 2025
$182.8M
Human Biochemical GeneticsZIAHG000215 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI GAHL, WILLIAM · 2009 to 2025
$72.6M
UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
MEDICAL GENETICS RESEARCH TRAINING GRANTT32GM008638 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca Ganetzky · 1997 to 2026
$8.7M
New Congenital Disorders of Glycosylation: Therapy and ModelsR01DK099551 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Hudson H. Freeze · 2014 to 2026
$6.7M
Carbohydrate Deficient Glycoprotein Syndromes: Models and TherapyR01DK055615 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FREEZE, HUDSON H. · 1999 to 2013
$4.4M
In Search of Mannolipid Intermediate FlippasesR01GM102129 · NIGMS · UNIVERSITY OF KENTUCKY · PI RUSH, JEFFREY STEWART, WAECHTER, CHARLES J · 2012 to 2015
$1.1M
NHGRI NIH HHS U01 HG007301NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NIDDK NIH HHS R01 DK055615NIDDK NIH HHS R01 DK099551NIGMS NIH HHS R01 GM102129NIGMS NIH HHS T32 GM008638
6 · The paper itself

Abstract

Congenital disorders of glycosylation (CDG) arise from pathogenic mutations in over 100 genes leading to impaired protein or lipid glycosylation. ALG1 encodes a β1,4 mannosyltransferase that catalyzes the addition of the first of nine mannose moieties to form a dolichol-lipid linked oligosaccharide intermediate required for proper N-linked glycosylation. ALG1 mutations cause a rare autosomal recessive disorder termed ALG1-CDG. To date 13 mutations in 18 patients from 14 families have been described with varying degrees of clinical severity. We identified and characterized 39 previously unreported cases of ALG1-CDG from 32 families and add 26 new mutations. Pathogenicity of each mutation was confirmed based on its inability to rescue impaired growth or hypoglycosylation of a standard biomarker in an alg1-deficient yeast strain. Using this approach we could not establish a rank order comparison of biomarker glycosylation and patient phenotype, but we identified mutations with a lethal outcome in the first two years of life. The recently identified protein-linked xeno-tetrasaccharide biomarker, NeuAc-Gal-GlcNAc2 , was seen in all 27 patients tested. Our study triples the number of known patients and expands the molecular and clinical correlates of this disorder.

Indexed as

MutationBiomarkersCongenital Disorders of GlycosylationFemaleGenes, LethalGlycosylationHumansMaleMannosyltransferasesPolysaccharidesSequence Analysis, DNASurvival AnalysisBiomarkerschitobiosyldiphosphodolichol beta-mannosyltransferaseMannosyltransferasesPolysaccharidesasparagine-linked glycosylation protein 1carbohydrate-deficient transferrinCDGxeno-tetrasaccharide

Identifiers

PMID26931382
PMCPMC4907823
OpenAlexW2302527860

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.